| Functional assessments in mice and rats after focal stroke AJ Hunter, J Hatcher, D Virley, P Nelson, E Irving, SJ Hadingham, ... Neuropharmacology 39 (5), 806-816, 2000 | 402 | 2000 |
| 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease N Upton, TT Chuang, AJ Hunter, DJ Virley Neurotherapeutics 5 (3), 458-469, 2008 | 294 | 2008 |
| Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex AJ Strong, PJ Anderson, HR Watts, DJ Virley, A Lloyd, EA Irving, ... Brain 130 (4), 995-1008, 2007 | 246 | 2007 |
| Rosiglitazone induces mitochondrial biogenesis in mouse brain JC Strum, R Shehee, D Virley, J Richardson, M Mattie, P Selley, S Ghosh, ... Journal of Alzheimer's disease 11 (1), 45-51, 2007 | 224 | 2007 |
| Conditionally immortalized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation JA Gray, G Grigoryan, D Virley, S Patel, JD Sinden, H Hodges Cell transplantation 9 (2), 153-168, 2000 | 166 | 2000 |
| The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B LP Quinn, B Crook, ME Hows, M Vidgeon‐Hart, H Chapman, N Upton, ... British journal of pharmacology 154 (1), 226-233, 2008 | 141 | 2008 |
| A new primate model of focal stroke: endothelin-1—induced middle cerebral artery occlusion and reperfusion in the common marmoset D Virley, SJ Hadingham, JC Roberts, B Farnfield, H Elliott, G Whelan, ... Journal of Cerebral Blood Flow & Metabolism 24 (1), 24-41, 2004 | 106 | 2004 |
| The quantification of gene expression in an animal model of brain ischaemia using TaqMan™ real-time RT-PCR BC Bond, DJ Virley, NJ Cairns, AJ Hunter, GBT Moore, SJ Moss, ... Molecular brain research 106 (1-2), 101-116, 2002 | 97 | 2002 |
| Primary CA1 and conditionally immortal MHP36 cell grafts restore conditional discrimination learning and recall in marmosets after excitotoxic lesions of the hippocampal CA1 field D Virley, RM Ridley, JD Sinden, TR Kershaw, S Harland, T Rashid, ... Brain 122 (12), 2321-2335, 1999 | 97 | 1999 |
| A temporal MRI assessment of neuropathology after transient middle cerebral artery occlusion in the rat: correlations with behavior D Virley, JS Beech, SC Smart, SCR Williams, H Hodges, AJ Hunter Journal of Cerebral Blood Flow & Metabolism 20 (3), 563-582, 2000 | 96 | 2000 |
| β-Secretase (BACE) and GSK-3 mRNA levels in Alzheimer’s disease P Preece, DJ Virley, M Costandi, R Coombes, SJ Moss, AW Mudge, ... Molecular brain research 116 (1-2), 155-158, 2003 | 87 | 2003 |
| Amyloid precursor protein mRNA levels in Alzheimer's disease brain P Preece, DJ Virley, M Costandi, R Coombes, SJ Moss, AW Mudge, ... Molecular brain research 122 (1), 1-9, 2004 | 72 | 2004 |
| Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP TR Cowley, J O'Sullivan, C Blau, BF Deighan, R Jones, C Kerskens, ... Neurobiology of aging 33 (1), 162-175, 2012 | 71 | 2012 |
| Developing therapeutics for the treatment of multiple sclerosis DJ Virley NeuroRx 2, 638-649, 2005 | 70 | 2005 |
| Cognitive deficits induced by global cerebral ischaemia: prospects for transplant therapy H Hodges, A Nelson, D Virley, TR Kershaw, JD Sinden Pharmacology Biochemistry and Behavior 56 (4), 763-780, 1997 | 68 | 1997 |
| Effects of the selective 5-HT7 receptor antagonist SB-269970 in animal models of psychosis and cognition KA Waters, TO Stean, B Hammond, DJ Virley, N Upton, JNC Kew, ... Behavioural Brain Research 228 (1), 211-218, 2012 | 66 | 2012 |
| An optimistic view for quantifying mRNA in post-mortem human brain P Preece, DJ Virley, M Costandi, R Coombes, SJ Moss, AW Mudge, ... Molecular brain research 116 (1-2), 7-16, 2003 | 63 | 2003 |
| Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? EA Irving, M Vinson, C Rosin, JC Roberts, DM Chapman, L Facci, ... Journal of Cerebral Blood Flow & Metabolism 25 (1), 98-107, 2005 | 60 | 2005 |
| Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is … M Sadeghian, L Marinova-Mutafchieva, L Broom, JB Davis, D Virley, ... Journal of neuroimmunology 246 (1-2), 69-77, 2012 | 59 | 2012 |
| The Neuroprotective Effect of a Specific P2X7 Receptor Antagonist Derives from its Ability to Inhibit Assembly of the NLRP3 Inflammasome in Glial Cells N Murphy, TR Cowley, JC Richardson, D Virley, N Upton, D Walter, ... Brain Pathology 22 (3), 295-306, 2012 | 57 | 2012 |
